These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27175330)

  • 1. E17110 promotes reverse cholesterol transport with liver X receptor β agonist activity in vitro.
    Li N; Wang X; Liu P; Lu D; Jiang W; Xu Y; Si S
    Acta Pharm Sin B; 2016 May; 6(3):198-204. PubMed ID: 27175330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Decline of ATP-binding cassette transporter G1 expressions with a liver X receptor-independent pathway in patients with type 2 diabetes].
    Wang HJ; Zhao XS; Sun HY; Chen LF; Yan XW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Dec; 46(6):899-905. PubMed ID: 25512280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astaxanthin enhances ATP-binding cassette transporter A1/G1 expressions and cholesterol efflux from macrophages.
    Iizuka M; Ayaori M; Uto-Kondo H; Yakushiji E; Takiguchi S; Nakaya K; Hisada T; Sasaki M; Komatsu T; Yogo M; Kishimoto Y; Kondo K; Ikewaki K
    J Nutr Sci Vitaminol (Tokyo); 2012; 58(2):96-104. PubMed ID: 22790567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpinetin enhances cholesterol efflux and inhibits lipid accumulation in oxidized low-density lipoprotein-loaded human macrophages.
    Jiang Z; Sang H; Fu X; Liang Y; Li L
    Biotechnol Appl Biochem; 2015; 62(6):840-7. PubMed ID: 25496323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid receptor agonists regulate expression of ATP-binding cassette transporter G1 in macrophages.
    Ayaori M; Yakushiji E; Ogura M; Nakaya K; Hisada T; Uto-Kondo H; Takiguchi S; Terao Y; Sasaki M; Komatsu T; Iizuka M; Yogo M; Uehara Y; Kagechika H; Nakanishi T; Ikewaki K
    Biochim Biophys Acta; 2012 Apr; 1821(4):561-72. PubMed ID: 22353356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foam cells in atherosclerosis.
    Yu XH; Fu YC; Zhang DW; Yin K; Tang CK
    Clin Chim Acta; 2013 Sep; 424():245-52. PubMed ID: 23782937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
    Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a selective agonist for liver X receptor α (LXRα) via screening of a synthetic compound library.
    Li N; Xu Y; Feng T; Liu C; Li Y; Wang X; Si S
    J Biomol Screen; 2014 Apr; 19(4):566-74. PubMed ID: 24334278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of liver X receptor agonist TO901317 on cognitive function in APP/PS1 double transgenic mice with Alzheimer
    Luo Y; Tan X; Zhang X; Li Y; Huang J; Deng Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1324-1331. PubMed ID: 36411683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages.
    Tang CK; Yi GH; Yang JH; Liu LS; Wang Z; Ruan CG; Yang YZ
    Acta Pharmacol Sin; 2004 May; 25(5):581-6. PubMed ID: 15132822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
    DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
    J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E3317 promotes cholesterol efflux in macrophage cells via enhancing ABCA1 expression.
    Wang X; Luo J; Li N; Liu L; Han X; Liu C; Zuo X; Jiang X; Li Y; Xu Y; Si S
    Biochem Biophys Res Commun; 2018 Sep; 504(1):68-74. PubMed ID: 30173890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligation of RAGE with ligand S100B attenuates ABCA1 expression in monocytes.
    Kumar P; Raghavan S; Shanmugam G; Shanmugam N
    Metabolism; 2013 Aug; 62(8):1149-58. PubMed ID: 23523156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent.
    Larrede S; Quinn CM; Jessup W; Frisdal E; Olivier M; Hsieh V; Kim MJ; Van Eck M; Couvert P; Carrie A; Giral P; Chapman MJ; Guerin M; Le Goff W
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1930-6. PubMed ID: 19729607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RXR agonists PA024 and HX630 have different abilities to activate LXR/RXR and to induce ABCA1 expression in macrophage cell lines.
    Nishimaki-Mogami T; Tamehiro N; Sato Y; Okuhira K; Sai K; Kagechika H; Shudo K; Abe-Dohmae S; Yokoyama S; Ohno Y; Inoue K; Sawada J
    Biochem Pharmacol; 2008 Oct; 76(8):1006-13. PubMed ID: 18761326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo.
    Ogura M; Ayaori M; Terao Y; Hisada T; Iizuka M; Takiguchi S; Uto-Kondo H; Yakushiji E; Nakaya K; Sasaki M; Komatsu T; Ozasa H; Ohsuzu F; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):1980-7. PubMed ID: 21817095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arctigenin promotes cholesterol efflux from THP-1 macrophages through PPAR-γ/LXR-α signaling pathway.
    Xu X; Li Q; Pang L; Huang G; Huang J; Shi M; Sun X; Wang Y
    Biochem Biophys Res Commun; 2013 Nov; 441(2):321-6. PubMed ID: 24140409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: findings from in vitro and ex vivo studies.
    Ozasa H; Ayaori M; Iizuka M; Terao Y; Uto-Kondo H; Yakushiji E; Takiguchi S; Nakaya K; Hisada T; Uehara Y; Ogura M; Sasaki M; Komatsu T; Horii S; Mochizuki S; Yoshimura M; Ikewaki K
    Atherosclerosis; 2011 Nov; 219(1):141-50. PubMed ID: 21862012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEK1/2 inhibitors activate macrophage ABCG1 expression and reverse cholesterol transport-An anti-atherogenic function of ERK1/2 inhibition.
    Zhang L; Chen Y; Yang X; Yang J; Cao X; Li X; Li L; Miao QR; Hajjar DP; Duan Y; Han J
    Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1180-1191. PubMed ID: 27365310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.